I
Isracann Biosciences Inc
CNSX:IPOT
Isracann Biosciences Inc
CNSX:IPOT
Price:
0.015
CAD
Market Closed
Market Cap:
CA$2.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Isracann Biosciences Inc
CNSX:IPOT
|
CA |
|
H
|
Hynion AS
OSE:HYN
|
NO |
Income Statement
Earnings Waterfall
Isracann Biosciences Inc
Isracann Biosciences Inc
Income Statement
Isracann Biosciences Inc
Isracann Biosciences Inc
Currency: CAD
| Aug-2012 | Nov-2012 | Feb-2013 | May-2013 | Aug-2013 | Nov-2013 | Feb-2014 | May-2014 | Aug-2014 | Nov-2014 | Feb-2015 | May-2015 | Aug-2015 | Nov-2015 | Feb-2016 | May-2016 | Aug-2016 | Nov-2016 | Feb-2017 | May-2017 | Aug-2017 | Nov-2017 | Feb-2018 | May-2018 | Aug-2018 | Nov-2018 | Feb-2019 | May-2019 | Aug-2019 | Nov-2019 | Feb-2020 | May-2020 | Aug-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+93%
|
0
+81%
|
0
+57%
|
0
+27%
|
0
+33%
|
0
+29%
|
0
+13%
|
0
+7%
|
0
+11%
|
0
+6%
|
0
+9%
|
0
+11%
|
1
+186%
|
2
+43%
|
3
+60%
|
3
+2%
|
0
-98%
|
1
+2 030%
|
1
-59%
|
0
-30%
|
0
-63%
|
0
+128%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-54%
|
0
N/A
|
0
+300%
|
0
-3%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(6)
|
(8)
|
(10)
|
(14)
|
(11)
|
(6)
|
(17)
|
(12)
|
(15)
|
(12)
|
(10)
|
(7)
|
(4)
|
(5)
|
(25)
|
(25)
|
(24)
|
(3)
|
(2)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(6)
|
(7)
|
(9)
|
(12)
|
(9)
|
(6)
|
(12)
|
(11)
|
(15)
|
(12)
|
(9)
|
(7)
|
(4)
|
(5)
|
(5)
|
(4)
|
(3)
|
(3)
|
(2)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(1)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
0
|
(5)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(21)
|
(20)
|
(21)
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
(0)
+10%
|
(0)
N/A
|
(0)
N/A
|
(0)
N/A
|
(0)
N/A
|
(0)
N/A
|
(0)
-11%
|
(0)
-90%
|
(0)
-137%
|
(1)
-22%
|
(1)
-8%
|
(1)
+2%
|
(0)
+24%
|
(0)
+2%
|
(0)
-1%
|
(1)
-20%
|
(1)
+2%
|
(1)
-6%
|
(1)
-3%
|
(1)
+5%
|
(2)
-258%
|
(6)
-199%
|
(6)
-12%
|
(8)
-30%
|
(11)
-37%
|
(9)
+25%
|
(6)
+34%
|
(16)
-188%
|
(11)
+31%
|
(15)
-34%
|
(12)
+22%
|
(9)
+20%
|
(7)
+24%
|
(4)
+44%
|
(5)
-23%
|
(25)
-417%
|
(25)
+2%
|
(24)
+5%
|
(3)
+89%
|
(2)
+8%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(4)
|
(8)
|
(8)
|
0
|
0
|
(0)
|
0
|
(12)
|
0
|
0
|
0
|
(21)
|
0
|
0
|
0
|
(1)
|
(1)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
+9%
|
(0)
N/A
|
(0)
N/A
|
(0)
+10%
|
(0)
N/A
|
(0)
+11%
|
(0)
-25%
|
(0)
-80%
|
(0)
-144%
|
(1)
-25%
|
(1)
-8%
|
(1)
+2%
|
(0)
+24%
|
(0)
+2%
|
(0)
-13%
|
(1)
-23%
|
(1)
-2%
|
(1)
-13%
|
(1)
-3%
|
(1)
+11%
|
(2)
-227%
|
(6)
-181%
|
(7)
-29%
|
(13)
-71%
|
(20)
-55%
|
(17)
+14%
|
(6)
+67%
|
(16)
-188%
|
(11)
+31%
|
(15)
-34%
|
(24)
-61%
|
(9)
+61%
|
(7)
+24%
|
(4)
+45%
|
(25)
-547%
|
(25)
+2%
|
(24)
+2%
|
(23)
+4%
|
(5)
+80%
|
(5)
+3%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(6)
|
(7)
|
(13)
|
(20)
|
(17)
|
(6)
|
(16)
|
(11)
|
(15)
|
(24)
|
(9)
|
(7)
|
(4)
|
(25)
|
(25)
|
(24)
|
(23)
|
(5)
|
(5)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
+9%
|
(0)
N/A
|
(0)
N/A
|
(0)
+10%
|
(0)
N/A
|
(0)
+11%
|
(0)
-25%
|
(0)
-80%
|
(0)
-144%
|
(1)
-25%
|
(1)
-8%
|
(1)
+2%
|
(0)
+24%
|
(0)
+2%
|
(0)
-13%
|
(1)
-23%
|
(1)
-2%
|
(1)
-13%
|
(1)
+3%
|
(1)
+12%
|
(2)
-242%
|
(6)
-185%
|
(7)
-30%
|
(13)
-71%
|
(20)
-55%
|
(17)
+14%
|
(10)
+41%
|
(21)
-107%
|
(15)
+24%
|
(19)
-25%
|
(24)
-25%
|
(9)
+61%
|
(7)
+24%
|
(4)
+45%
|
(25)
-541%
|
(25)
+2%
|
(24)
+2%
|
(23)
+4%
|
(5)
+80%
|
(5)
+3%
|
|
| EPS (Diluted) |
-0.05
N/A
|
-0.05
N/A
|
-0.05
N/A
|
-0.04
+20%
|
-0.04
N/A
|
-0.04
N/A
|
-0.04
N/A
|
-0.04
N/A
|
-0.03
+25%
|
-0.11
-267%
|
-0.13
-18%
|
-0.15
-15%
|
-0.12
+20%
|
-0.08
+33%
|
-0.07
+12%
|
-0.09
-29%
|
-0.1
-11%
|
-0.11
-10%
|
-0.12
-9%
|
-0.12
N/A
|
-0.05
+58%
|
-0.04
+20%
|
-0.16
-300%
|
-0.33
-106%
|
-0.35
-6%
|
-0.52
-49%
|
-0.14
+73%
|
-0.25
-79%
|
-0.53
-112%
|
-0.15
+72%
|
-0.16
-7%
|
-0.26
-63%
|
-0.08
+69%
|
-0.06
+25%
|
-0.03
+50%
|
-0.18
-500%
|
-0.17
+6%
|
-0.17
N/A
|
-0.16
+6%
|
-0.03
+81%
|
-0.03
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
